Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
6.27
-0.04 (-0.56%)
At close: Nov 7, 2025, 4:00 PM EST
6.26
0.00 (-0.08%)
After-hours: Nov 7, 2025, 7:53 PM EST
Predictive Oncology Market Cap
Predictive Oncology has a market cap or net worth of $26.38 million as of November 7, 2025. Its market cap has increased by 508.84% in one year.
Market Cap
26.38M
Enterprise Value
27.99M
1-Year Change
508.84%
Ranking
Category
Stock Price
$6.27
Market Cap Chart
Since April 9, 2010, Predictive Oncology's market cap has increased from $1.69M to $26.38M, an increase of 1,463.72%. That is a compound annual growth rate of 19.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 26.53M | 385.32% |
| Dec 31, 2024 | 5.47M | -59.10% |
| Dec 29, 2023 | 13.37M | -44.64% |
| Dec 30, 2022 | 24.15M | -61.32% |
| Dec 31, 2021 | 62.42M | 382.16% |
| Dec 31, 2020 | 12.95M | 26.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |